Explore AI in drug discovery and its journey from promise to proof in 2025 with significant achievements and challenges faced.

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

Artificial intelligence promised to transform drug discovery but struggled to deliver. A new focus on validation and ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Traditional drug research has focused on creating inhibitors that occupy the active areas of disease-related proteins, preventing them from functioning properly. But this strategy leaves a ...

A day after surpassing its own expectations with dazzling Phase III data for its lead pipeline candidate, the oral ulcerative colitis (UC) drug obefazimod, Abivax (Euronext Paris and NASDAQ: ABVX) so ...